Brain Aβ deposition
1 paper1 finding
- Humans1
Associations
1Boston Naming Test
downin humans1
1 study
Boston Naming Test
downin humans1
Brain Aβ deposition predicts boston Naming Test in humans (β = -0.38, p = 0.00435).
“Baseline whole‐brain Aβ deposition predicted longitudinal changes in the Boston Naming Test (BNT, β= ‐0.38, p = 0.00435)”
Humansbrain2 years
AAIC 2025 abstract26 Dec 2025
Latest
5 in 12 monthsExperimental Neurology
Fluid amyloid-β (Aβ) biomarkers reflect early β-sheet-rich Aβ deposition during the preclinical stage in Alzheimer's disease model 5XFAD mice
Experiments in miceBiomarkers
Journal of Alzheimer's Disease
Comparison of baseline characteristics between cognitively normal and mild cognitive impairment and association of white matter hyperintensity trajectories with diagnostic outcomes, cognition, and amyloid-β protein: A longitudinal study
Cohort study of 857 peopleMild cognitive impairment
medRxiv
Association of total and brain-derived Alzheimer's disease plasma biomarkers with brain amyloid deposition in a community-based sample
Preprint: cohort study of 541 peopleBiomarkers
AAIC 2025 Abstract
Study of Predicting Longitudinal Cognitive Changes with “AN” Imaging Biomarkers in Subjective Cognitive Decline
Cohort study of 95 peopleSubjective cognitive decline
AAIC 2025 Abstract
Study on the Imaging Characteristics of β‐Amyloid (Aβ) Deposition (A) and Neurodegeneration (N) in Subjective Cognitive Decline
Cross-sectional study of 144 peopleSubjective cognitive decline